Clearance Summary
PRIMUS RAPID GEL 100 GLYCATED HEMOGLOBIN ASSAY received FDA 510(k) clearance under submission number K942009, sponsored by Primus Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1994-09-14.
- Submission: K942009
- Applicant / Sponsor: Primus Corp.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7470
- Decision date: 1994-09-14
Classification & Regulation
This clearance is catalogued under FDA product code LCP and 21 CFR 864.7470, within the Hematology review panel as a Class II device.